source Post navigation Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic Nephropathy – PR Newswire Palatin's Bremelanotide Shows Promising Phase 2b Results for Diabetic Kidney Disease Treatment – StockTitan